Nureca Limited Reports 18.28 percent Growth for Q3 FY25, Releases Strategic Plan for FY26

▴ Nureca Limited
Strong Financial Performance - 18.28% growth in sales. Sales revenue jumped by 18.28 % from ₹ 22.37 cr in Q3 FY 23-34 to ₹26.46 cr in Q3 FY 24-25

 

Nureca Limited reports 18.28% growth for Q3 FY25, Releases Strategic Plan for FY26

 

Short-Term Strategic Plan for business growth for FY 25 & 26
Nureca aims to drive revenue growth exponentially, by launching new categories, expanding its product range, and strengthening partnerships with quick-commerce platforms Zepto & Blinkit to enhance product availability and customer satisfaction. The company plans to replicate its success at Flipkart with Amazon and other e-commerce platforms while expanding offline into 500+ cities through a robust distributor network. It is also focusing on emerging channels such as exports and corporate sales, supported by a team of experts. On the profitability front, Nureca is committed to improving EBITDA through operational efficiencies and cost optimization, introducing 27 new SKUs, and entering four new categories with optimized costs. Leveraging AI and data analytics, the company aims to enhance efficiency and reduce operational costs further.

 

Key Managerial Personnel Appointment
Ms. Nishu Kansal appointed as Company Secretary and Compliance Officer, effective February 1, 2025.


I would like to take this opportunity to express my gratitude to our shareholders for their continued confidence in Nureca. We are excited about the opportunities that lie ahead and are committed to delivering strong results in the coming quarters.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Budget 2024- 25’s Healthcare Push: Real Reform or Just Another Election Strategy?February 03, 2025
FedEx Remains Highest Ranked Delivery Company on Fortune’s “World’s Most Admired Companies” Overall List February 03, 2025
FedEx Remains Highest Ranked Delivery Company on Fortune’s “World’s Most Admired Companies” Overall List February 03, 2025
Amrita Vishwa Vidyapeetham To Host A Three-Day International Conference on "Synergizing Eco Interventions for Achieving SDGs”January 31, 2025
Cotecna Life Sciences India Inaugurates New Laboratory in MumbaiJanuary 31, 2025
Senior Citizens vs. Insurance Giants: IRDAI Puts an End to Exploitative Premium HikesJanuary 31, 2025
Two Deaths, 130 Cases: Is Contaminated Water Fuelling the Guillain-Barre Surge in Maharashtra?January 31, 2025
Wellbeing Nutrition ropes in Sharvari as the brand ambassador to simplify nutrition January 30, 2025
58,000 Lives Lost Every Year: Why Snakebite Victims in India Are Dying NeedlesslyJanuary 30, 2025
Three Deaths, One Rare Disease: Is West Bengal Facing an Undetected Health Crisis?January 30, 2025
The Silent Monthly Struggle: How Periods Are Still Holding Women BackJanuary 30, 2025
Dr. Pooja Chopra - Consultant Dermatology - Aakash Healthcare, New Delhi Leprosy Day and Public Health: Promoting Early Diagnosis and Support for Affected CommunitiesJanuary 30, 2025
Moscow scientists have developed 11 medical phantoms to enhance Patient DiagnosisJanuary 29, 2025
Using AI to Predict the Outcome of Aggressive Skin CancersJanuary 29, 2025
A Baby Within a Baby: Doctors Stunned as Maharashtra Woman’s Baby Is Found Carrying a TwinJanuary 29, 2025
Ageing with Dignity: The Multi-Crore Investment in Geri Care That would Change Elderly Care ForeverJanuary 29, 2025
Revolutionizing Healthcare at Maha Kumbh Mela 2025: Lifesigns and AIIMS Transform Patient Monitoring with Advanced TechnologyJanuary 29, 2025
Is AI Making Us Less Intelligent? The Hidden Cost of ConvenienceJanuary 28, 2025
The Biotech Startup Giving Chemotherapy a New Lease on LifeJanuary 28, 2025
Guillain-Barré Syndrome: Experts Recommend Early Detection and Advanced Care Amid Rising CasesJanuary 28, 2025